Burke William P. Mr. 4
4 · Axogen, Inc. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Axogen (AXGN) Director William P. Burke Receives RSU Award
What Happened William P. Burke, a member of Axogen, Inc.'s Board of Directors, was granted 4,392 restricted stock units (RSUs) on June 24, 2026. The RSUs were issued at no cash price ($0.00) as an award (transaction code A) and represent a contingent right to receive one share of common stock per unit. The grant is valued at $185,000 on the grant date and vests on June 24, 2027 (one-year cliff).
Key Details
- Transaction date and filing: Grant dated 2026-06-24; Form 4 filed 2026-06-26 (timely for typical Section 16 reporting).
- Award: 4,392 RSUs acquired at $0.00 (derivative award).
- Reported value: Grant valued at $185,000 per company disclosure.
- Vesting: 100% vests on 2027-06-24 (one-year anniversary).
- Shares owned after transaction: Not specified in the filing.
- Footnotes: F1 — each RSU converts to one share upon settlement; F2 — annual director equity grant based on $185,000 valuation and one-year vesting.
- Transaction type: Director compensation award (routine, not a market purchase or sale).
Context RSU grants to directors are standard compensation and do not involve an out‑of‑pocket purchase. These awards are derivative (contingent rights to future shares) and should be viewed as routine board compensation rather than a direct buy/sell signal.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-06-24+4,392→ 4,392 total→ Common Stock (4,392 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F2]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.